by Katie Bales | Apr 24, 2025 | Uncategorized
Houston, TX — April 24, 2025 — PolyVascular, a pioneering medical device company developing the first polymer-based transcatheter pulmonary valve designed specifically for young children, announced today that it has been awarded a $3 million Small Business Innovation...
by Katie Bales | Oct 1, 2024 | Uncategorized
PolyVascular, a pioneering medtech company focused on developing innovative transcatheter valve solutions for children with congenital heart disease, is proud to announce its acceptance to present at the prestigious Transcatheter Cardiovascular Therapeutics (TCT) 2024...
by Katie Bales | Sep 5, 2024 | Uncategorized
PolyVascular’s Co-Founder, Dr. Henri Justino, and Engineering Manager, Kelly McKinzey, presented the latest findings from PolyVascular’s preclinical animal study at the 2024 Annual PICS Symposium. The presentation, titled “In Vivo Chronic Performance of a...
by Katie Bales | Jun 1, 2024 | Uncategorized
PolyVascular, a pioneering company focused on developing the world’s first polymeric, non-surgical pulmonary valve for pediatric patients, is excited to announce that Steven Girouard, PhD, an accomplished medical device executive and consultant, has joined its Board...
by Will Clifton | Jul 12, 2023 | Uncategorized
Today, PolyVascular is excited to announce a strategic collaboration with CobiCure which includes advisory and strategic expertise, along with $2 million in grant funding. CobiCure is a non-profit pediatric initiative with a mission to solve unmet needs in pediatric...
by sashawhitaker@gmail.com | Nov 26, 2022 | Uncategorized
PolyVascular Hires Will Clifton, MD, as COO to Manage Path to Human Trials in US; Ultimate Goal to Help 1 Million Pediatric Patients With Congenital Heart Disease Around the World With More Dependable and Affordable Solution Houston, TX — March 30, 2021 —...
